Active Pharmaceutical Ingredient (API)

Delamanid

Novel Anti-Tuberculosis Agent (Nitro-Dihydro-Imidazooxazole)

A novel $\text{nitro-dihydro-imidazooxazole}$ used to treat $\text{MDR-TB}$. It is a $\text{prodrug}$ that targets and inhibits the synthesis of $\text{mycolic acid}$ and cell wall components. It is a critical, but high-cost, addition to $\text{MDR-TB}$ regimens.
Technical Profile
Reference Code
DEL538
CAS Number
681492-26-4
Molecular Weight
542.49 g/mol
Chemical Class
N/A
Molecular Formula
C25H25F3N4O6
Therapeutic Class
N/A

Verified Brands

Medicines containing Delamanid as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.